Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Is there a Relationship Between Vitamin D and Endometriosis? An Overview of the Literature

Author(s): Pierluigi Giampaolino, Luigi D. Corte*, Virginia Foreste and Giuseppe Bifulco

Volume 25, Issue 22, 2019

Page: [2421 - 2427] Pages: 7

DOI: 10.2174/1381612825666190722095401

Price: $65

Abstract

Background: Vitamin D is involved in the physiological functions of several tissues, however, its deficiency may contribute to the development of various disorders. Recent research has been focusing on the role of vitamin D in the pathogenesis of endometriosis based on the evidence of the presence of vitamin D receptor and the enzymes required for vitamin D synthesis in the ectopic endometrium. Endometriosis, defined as the presence of endometrial glands and stroma in ectopic locations, is considered an estrogen-dependent disease and Vitamin D seems to have a role in modulation of the inflammatory state and proliferation of endometriotic cells.

Objective: This study aimed to review the available literature regarding the relationship between vitamin D and endometriosis as well as the effects of vitamin D supplementation.

Methods: A search on PubMed database has been performed.

Results: The relationship between endometriosis and Vitamin D has been analyzed through the evaluation of vitamin D serum level, the polymorphism of vitamin D receptor and the role of vitamin D-binding protein in patient with endometriosis. The possible role of Vitamin D in the endometriosis therapy has also been investigated, in particular, the effect of vitamin D on pain relief, on endometriotic lesion in vitro and in rat models and in addition to a future target immunotherapy.

Conclusion: Although promising, the data analyzed are not sufficient to evidence a cause-effect relationship between VD status and endometriosis, therefore further studies are needed in order to better clarify the association between vitamin D and endometriosis, especially in the context of the possibility of new treatment options.

Keywords: Vitamin D, vitamin D binding protein, vitamin D receptor, vitamin D supplementation, female fertility, endometriosis.

« Previous Next »
[1]
Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008; 88(2): 491S-9S.
[http://dx.doi.org/10.1093/ajcn/88.2.491S] [PMID: 18689389]
[2]
Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005; 26(5): 662-87.
[http://dx.doi.org/10.1210/er.2004-0002] [PMID: 15798098]
[3]
Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998; 78(4): 1193-231.
[http://dx.doi.org/10.1152/physrev.1998.78.4.1193] [PMID: 9790574]
[4]
Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 2005; 35(5): 290-304.
[http://dx.doi.org/10.1111/j.1365-2362.2005.01487.x] [PMID: 15860041]
[5]
Bouillon R, Carmeliet G. Vitamin D insufficiency: Definition, diagnosis and management. Best Pract Res Clin Endocrinol Metab 2018; 32(5): 669-84.
[http://dx.doi.org/10.1016/j.beem.2018.09.014] [PMID: 30449548]
[6]
Della Corte L, La Rosa VL, Rapisarda AMC, et al. Current evidences and future perspectives on patient-oriented treatments for polycystic ovary syndrome: An overview. Ital J Gynaecol Obstet 2018; 30(1): 2385.
[7]
Colonese F, Laganà AS, Colonese E, et al. The pleiotropic effects of vitamin D in gynaecological and obstetric diseases: An overview on a hot topic. BioMed Res Int 2015; 2015986281
[http://dx.doi.org/10.1155/2015/986281] [PMID: 26000308]
[8]
Giudice LC, Kao LC. Endometriosis. Lancet 2004; 364(9447): 1789-99.
[http://dx.doi.org/10.1016/S0140-6736(04)17403-5] [PMID: 15541453]
[9]
Ceccaroni M, Clarizia R, Placci A. Pericardial, pleural, and diaphragmatic endometriosis. J Thorac Cardiovasc Surg 2010; 140(5): 1189-90.
[http://dx.doi.org/10.1016/j.jtcvs.2010.07.064] [PMID: 20951262]
[10]
Ceccaroni M, Roviglione G, Giampaolino P, et al. Laparoscopic surgical treatment of diaphragmatic endometriosis: A 7-year single-institution retrospective review. Surg Endosc 2013; 27(2): 625-32.
[http://dx.doi.org/10.1007/s00464-012-2505-z] [PMID: 22955897]
[11]
Thomas EJ, Campbell IG. Evidence that endometriosis behaves in a malignant manner. Gynecol Obstet Invest 2000; 50(Suppl. 1): 2-10.
[http://dx.doi.org/10.1159/000052872] [PMID: 11093055]
[12]
Matarese G, De Placido G, Nikas Y, Alviggi C. Pathogenesis of endometriosis: Natural immunity dysfunction or autoimmune disease? Trends Mol Med 2003; 9(5): 223-8.
[http://dx.doi.org/10.1016/S1471-4914(03)00051-0] [PMID: 12763528]
[13]
Eisenberg VH, Zolti M, Soriano D. Is there an association between autoimmunity and endometriosis? Autoimmun Rev 2012; 11(11): 806-14.
[http://dx.doi.org/10.1016/j.autrev.2012.01.005] [PMID: 22330229]
[14]
DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004; 80(6)(Suppl.): 1689S-96S.
[http://dx.doi.org/10.1093/ajcn/80.6.1689S] [PMID: 15585789]
[15]
Lehmann B. The vitamin D3 pathway in human skin and its role for regulation of biological processes. Photochem Photobiol 2005; 81(6): 1246-51.
[http://dx.doi.org/10.1562/2005-02-02-IR-430] [PMID: 16162035]
[16]
Holick MF. McCollum Award Lecture, 1994: Vitamin D-new horizons for the 21st century. Am J Clin Nutr 1994; 60(4): 619-30.
[http://dx.doi.org/10.1093/ajcn/60.4.619] [PMID: 8092101]
[17]
Braun A, Kofler A, Morawietz S, Cleve H. Sequence and organization of the human vitamin D-binding protein gene. Biochim Biophys Acta 1993; 1216: 385-94.
[18]
Song YH, Naumova AK, Liebhaber SA, Cooke NE. Physical and meiotic mapping of the region of human chromosome 4q11-q13 encompassing the vitamin D binding protein DBP/Gc-globulin and albumin multigene cluster. Genome Res 1999; 9: 581e7.
[19]
Knutson JC, DeLuca HF. 25-Hydroxyvitamin D3-24-hydroxylase. Subcellular location and properties. Biochemistry 1974; 13(7): 1543-8.
[http://dx.doi.org/10.1021/bi00704a034] [PMID: 4150615]
[20]
Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004; 80(6)(Suppl.): 1678S-88S.
[http://dx.doi.org/10.1093/ajcn/80.6.1678S] [PMID: 15585788]
[21]
Adorini L. Intervention in autoimmunity: The potential of vitamin D receptor agonists. Cell Immunol 2005; 233(2): 115-24.
[http://dx.doi.org/10.1016/j.cellimm.2005.04.013] [PMID: 15936743]
[22]
Muscogiuri G, Altieri B, de Angelis C, et al. Shedding new light on female fertility: The role of vitamin D. Rev Endocr Metab Disord 2017; 18(3): 273-83.
[http://dx.doi.org/10.1007/s11154-017-9407-2] [PMID: 28102491]
[23]
Osuga Y, Koga K, Hirota Y, Hirata T, Yoshino O, Taketani Y. Lymphocytes in endometriosis. Am J Reprod Immunol 2011; 65(1): 1-10.
[http://dx.doi.org/10.1111/j.1600-0897.2010.00887.x] [PMID: 20584009]
[24]
van Etten E, Stoffels K, Gysemans C, Mathieu C, Overbergh L. Regulation of vitamin D homeostasis: Implications for the immune system. Nutr Rev 2008; 66(10)(Suppl. 2): S125-34.
[http://dx.doi.org/10.1111/j.1753-4887.2008.00096.x] [PMID: 18844839]
[25]
Sayegh L. Fuleihan Gel-H, Nassar AH. Vitamin D in endometriosis: a causative or confounding factor? Metabolism 2014; 63(1): 32-41.
[http://dx.doi.org/10.1016/j.metabol.2013.09.012] [PMID: 24135500]
[26]
Harris HR, Chavarro JE, Malspeis S, Willett WC, Missmer SA. Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: A prospective cohort study. Am J Epidemiol 2013; 177(5): 420-30.
[http://dx.doi.org/10.1093/aje/kws247] [PMID: 23380045]
[27]
Miyashita M, Koga K, Izumi G, et al. Effects of 1,25-Dihydroxy Vitamin D3 on Endometriosis. J Clin Endocrinol Metab 2016; 101(6): 2371-9.
[http://dx.doi.org/10.1210/jc.2016-1515] [PMID: 27035829]
[28]
Ciavattini A, Serri M, Delli Carpini G, Morini S, Clemente N. Ovarian endometriosis and vitamin D serum levels. Gynecol Endocrinol 2017; 33(2): 164-7.
[http://dx.doi.org/10.1080/09513590.2016.1239254] [PMID: 27809683]
[29]
Hartwell D, Rødbro P, Jensen SB, Thomsen K, Christiansen C. Vitamin D metabolites-relation to age, menopause and endometriosis. Scand J Clin Lab Invest 1990; 50(2): 115-21.
[http://dx.doi.org/10.3109/00365519009089142] [PMID: 2339276]
[30]
Agic A, Xu H, Altgassen C, et al. Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reprod Sci 2007; 14(5): 486-97.
[http://dx.doi.org/10.1177/1933719107304565] [PMID: 17913968]
[31]
Borkowski J, Gmyrek GB, Madej JP, et al. Serum and peritoneal evaluation of vitamin D-binding protein in women with endometriosis. Postepy Hig Med Dosw 2008; 62: 103-9.
[PMID: 18334925]
[32]
Somigliana E, Panina-Bordignon P, Murone S, Di Lucia P, Vercellini P, Vigano P. Vitamin D reserve is higher in women with endometriosis. Hum Reprod 2007; 22(8): 2273-8.
[http://dx.doi.org/10.1093/humrep/dem142] [PMID: 17548365]
[33]
Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 2017; 18(2): 153-65.
[http://dx.doi.org/10.1007/s11154-017-9424-1] [PMID: 28516265]
[34]
Pike JW, Meyer MB, Lee SM, Onal M, Benkusky NA. The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights. J Clin Invest 2017; 127(4): 1146-54.
[http://dx.doi.org/10.1172/JCI88887] [PMID: 28240603]
[35]
Vilarino FL, Bianco B, Lerner TG, et al. Analysis of vitamin D receptor gene polymorphisms in women with and without endometriosis. Hum Immunol 2011; 72(4): 359-63.
[http://dx.doi.org/10.1016/j.humimm.2011.01.006] [PMID: 21277927]
[36]
Delanghe JR, Speeckaert R, Speeckaert MM. Behind the scenes of vitamin D binding protein: more than vitamin D binding. Best Pract Res Clin Endocrinol Metab 2015; 29(5): 773-86.
[http://dx.doi.org/10.1016/j.beem.2015.06.006] [PMID: 26522461]
[37]
Jørgensen CS, Christiansen M, Nørgaard-Pedersen B, et al. Gc globulin (vitamin D-binding protein) levels: An inhibition ELISA assay for determination of the total concentration of Gc globulin in plasma and serum. Scand J Clin Lab Invest 2004; 64(2): 157-66.
[http://dx.doi.org/10.1080/00365510410001149] [PMID: 15115254]
[38]
Speeckaert M, Huang G, Delanghe JR, Taes YE. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 2006; 372(1-2): 33-42.
[http://dx.doi.org/10.1016/j.cca.2006.03.011] [PMID: 16697362]
[39]
Ferrero S, Gillott DJ, Anserini P, et al. Vitamin D binding protein in endometriosis. J Soc Gynecol Investig 2005; 12(4): 272-7.
[http://dx.doi.org/10.1016/j.jsgi.2005.01.027] [PMID: 15866120]
[40]
Harada T, Iwabe T, Terakawa N. Role of cytokines in endometriosis. Fertil Steril 2001; 76(1): 1-10.
[http://dx.doi.org/10.1016/S0015-0282(01)01816-7] [PMID: 11438312]
[41]
Cho S, Choi YS, Yim SY, et al. Urinary vitamin D-binding protein is elevated in patients with endometriosis. Hum Reprod 2012; 27(2): 515-22.
[http://dx.doi.org/10.1093/humrep/der345] [PMID: 22158084]
[42]
Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D. Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest 2006; 62(3): 139-47.
[http://dx.doi.org/10.1159/000093121] [PMID: 16679772]
[43]
Cooke NE, McLeod JF, Wang XK, Ray K. Vitamin D binding protein: genomic structure, functional domains, and mRNA expression in tissues. J Steroid Biochem Mol Biol 1991; 40: 787-93.
[44]
Liu E, Nisenblat V, Farquhar C, et al. Urinary biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2015; (12): CD012019
[http://dx.doi.org/10.1002/14651858.CD012019] [PMID: 26695425]
[45]
Berger D, Beger HG. Evidence for endotoxin binding capacity of human Gc-globulin and transferrin. Clin Chim Acta 1987; 163(3): 289-99.
[http://dx.doi.org/10.1016/0009-8981(87)90247-6] [PMID: 3555889]
[46]
Williams MH, Van Alstyne EL, Galbraith RM. Evidence of a novel association of unsaturated fatty acids with Gc (vitamin D-binding protein). Biochem Biophys Res Commun 1988; 153(3): 1019-24.
[http://dx.doi.org/10.1016/S0006-291X(88)81330-5] [PMID: 3134016]
[47]
Lee WM, Galbraith RM. The extracellular actin-scavenger system and actin toxicity. N Engl J Med 1992; 326(20): 1335-41.
[http://dx.doi.org/10.1056/NEJM199205143262006] [PMID: 1314333]
[48]
Kew RR, Webster RO. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg. J Clin Invest 1988; 82(1): 364-9.
[http://dx.doi.org/10.1172/JCI113596] [PMID: 3392213]
[49]
Perez HD, Kelly E, Chenoweth D, Elfman F. Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin). J Clin Invest 1988; 82(1): 360-3.
[http://dx.doi.org/10.1172/JCI113595] [PMID: 3392212]
[50]
Piquette CA, Robinson-Hill R, Webster RO. Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by Gc-globulin. J Leukoc Biol 1994; 55(3): 349-54.
[http://dx.doi.org/10.1002/jlb.55.3.349] [PMID: 8120452]
[51]
Yamamoto N, Naraparaju VR. Role of vitamin D3-binding protein in activation of mouse macrophages. J Immunol 1996; 157(4): 1744-9.
[PMID: 8759764]
[52]
Nagasawa H, Uto Y, Sasaki H, et al. Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity. Anticancer Res 2005; 25(6A): 3689-95.
[PMID: 16302727]
[53]
Gomme PT, Bertolini J. Therapeutic potential of vitamin D-binding protein. Trends Biotechnol 2004; 22(7): 340-5.
[http://dx.doi.org/10.1016/j.tibtech.2004.05.001] [PMID: 15245906]
[54]
Gumireddy K, Reddy CD, Swamy N. Mitogen-activated protein kinase pathway mediates DBP-maf-induced apoptosis in RAW 264.7 macrophages. J Cell Biochem 2003; 90(1): 87-96.
[http://dx.doi.org/10.1002/jcb.10615] [PMID: 12938159]
[55]
Szczepańska M, Mostowska A, Wirstlein P, Skrzypczak J, Misztal M, Jagodziński PP. Polymorphic variants in vitamin D signaling pathway genes and the risk of endometriosis-associated infertility. Mol Med Rep 2015; 12(5): 7109-15.
[http://dx.doi.org/10.3892/mmr.2015.4309] [PMID: 26398313]
[56]
Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 1927; 3(93-110): 43.
[57]
Vetvicka V, Laganà AS, Salmeri FM, et al. Regulation of apoptotic pathways during endometriosis: From the molecular basis to the future perspectives. Arch Gynecol Obstet 2016; 294(5): 897-904.
[http://dx.doi.org/10.1007/s00404-016-4195-6] [PMID: 27628753]
[58]
Xavier P, Belo L, Beires J, et al. Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet 2006; 273(4): 227-31.
[http://dx.doi.org/10.1007/s00404-005-0080-4] [PMID: 16208475]
[59]
Yamamoto N, Naraparaju VR, Moore M, Brent LH. Deglycosylation of serum vitamin D3-binding protein by alpha-N-acetylgalactosaminidase detected in the plasma of patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1997; 82(3): 290-8.
[http://dx.doi.org/10.1006/clin.1996.4320] [PMID: 9073553]
[60]
Ho HN, Wu MY, Yang YS. Peritoneal cellular immunity and endometriosis. Am J Reprod Immunol 1997; 38(6): 400-12.
[http://dx.doi.org/10.1111/j.1600-0897.1997.tb00319.x] [PMID: 9412723]
[61]
van Hoof HJ, de Sévaux RG, van Baelen H, et al. Relationship between free and total 1,25-dihydroxyvitamin D in conditions of modified binding. Eur J Endocrinol 2001; 144(4): 391-6.
[http://dx.doi.org/10.1530/eje.0.1440391] [PMID: 11275949]
[62]
Faserl K, Golderer G, Kremser L, et al. Polymorphism in vitamin D-binding protein as a genetic risk factor in the pathogenesis of endometriosis. J Clin Endocrinol Metab 2011; 96(1): E233-41.
[http://dx.doi.org/10.1210/jc.2010-1532] [PMID: 20980430]
[63]
Facchin F, Barbara G, Saita E, et al. Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference. J Psychosom Obstet Gynaecol 2015; 36(4): 135-41.
[http://dx.doi.org/10.3109/0167482X.2015.1074173] [PMID: 26328618]
[64]
Bourdel N, Alves J, Pickering G, Ramilo I, Roman H, Canis M. Systematic review of endometriosis pain assessment: How to choose a scale? Hum Reprod Update 2015; 21(1): 136-52.
[http://dx.doi.org/10.1093/humupd/dmu046] [PMID: 25180023]
[65]
Giampaolino P, Bifulco G, Di Spiezio Sardo A, Mercorio A, Bruzzese D, Di Carlo C. Endometrioma size is a relevant factor in selection of the most appropriate surgical technique: a prospective randomized preliminary study. Eur J Obstet Gynecol Reprod Biol 2015; 195: 88-93.
[http://dx.doi.org/10.1016/j.ejogrb.2015.09.046] [PMID: 26492167]
[66]
Sansone A, De Rosa N, Giampaolino P, Guida M, Laganà AS, Di Carlo C. Effects of etonogestrel implant on quality of life, sexual function, and pelvic pain in women suffering from endometriosis: results from a multicenter, prospective, observational study. Arch Gynecol Obstet 2018; 298(4): 731-6.
[http://dx.doi.org/10.1007/s00404-018-4851-0] [PMID: 30074068]
[67]
Anastasi E, Fuggetta E, De Vito C, et al. Low levels of 25-OH vitamin D in women with endometriosis and associated pelvic pain. Clin Chem Lab Med 2017; 55(12): e282-4.
[http://dx.doi.org/10.1515/cclm-2017-0016] [PMID: 28453438]
[68]
Parazzini F, Esposito G, Tozzi L, Noli S, Bianchi S. Epidemiology of endometriosis and its comorbidities. Eur J Obstet Gynecol Reprod Biol 2017; 209: 3-7.
[http://dx.doi.org/10.1016/j.ejogrb.2016.04.021] [PMID: 27216973]
[69]
Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 2011; 51: 311-36.
[http://dx.doi.org/10.1146/annurev-pharmtox-010510-100611] [PMID: 20936945]
[70]
Lasco A, Catalano A, Benvenga S. Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: Results of a randomized, double-blind, placebo-controlled study. Arch Intern Med 2012; 172(4): 366-7.
[http://dx.doi.org/10.1001/archinternmed.2011.715] [PMID: 22371927]
[71]
Laganà AS, Vitale SG, Ban Frangež H, Vrtačnik-Bokal E, D’Anna R. Vitamin D in human reproduction: The more, the better? An evidence-based critical appraisal. Eur Rev Med Pharmacol Sci 2017; 21(18): 4243-51.
[PMID: 29028072]
[72]
Colonese F, La Rosa VL, Laganà AS, Vitale SG, Cortinovis D, Bidoli P. Comment on: “Is there a role for vitamin D in human reproduction? Horm Mol Biol Clin Investig 2017; 29(1): 37-8.
[PMID: 27740917]
[73]
Almassinokiani F, Khodaverdi S, Solaymani-Dodaran M, Akbari P, Pazouki A. Effects of vitamin D on endometriosis-related pain: A double-blind clinical trial. Med Sci Monit 2016; 22: 4960-6.
[http://dx.doi.org/10.12659/MSM.901838] [PMID: 27986972]
[74]
Abbas MA, Taha MO, Disi AM, Shomaf M. Regression of endometrial implants treated with vitamin D3 in a rat model of endometriosis. Eur J Pharmacol 2013; 715(1-3): 72-5.
[http://dx.doi.org/10.1016/j.ejphar.2013.06.016] [PMID: 23810684]
[75]
Mariani M, Viganò P, Gentilini D, et al. The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation. Hum Reprod 2012; 27(7): 2010-9.
[http://dx.doi.org/10.1093/humrep/des150] [PMID: 22588001]
[76]
Delbandi AA, Mahmoudi M, Shervin A, Zarnani AH. 1,25-dihydroxy vitamin D3 modulates endometriosis-related features of human endometriotic stromal cells. Am J Reprod Immunol 2016; 75(4): 461-73.
[http://dx.doi.org/10.1111/aji.12463] [PMID: 26691009]
[77]
Miyashita M, Koga K, Izumi G, et al. Effects of 1,25-dihydroxy vitamin D3 on endometriosis. J Clin Endocrinol Metab 2016; 101(6): 2371-9.
[http://dx.doi.org/10.1210/jc.2016-1515] [PMID: 27035829]
[78]
Artaza JN, Sirad F, Ferrini MG, Norris KC. 1,25(OH)2vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells. J Steroid Biochem Mol Biol 2010; 119(1-2): 73-83.
[http://dx.doi.org/10.1016/j.jsbmb.2010.01.001] [PMID: 20064609]
[79]
Mormile R, Vittori G. Vitamin D intake and endometriosis: The good and the bad. Eur J Obstet Gynecol Reprod Biol 2014; 177: 152-3.
[http://dx.doi.org/10.1016/j.ejogrb.2014.02.023] [PMID: 24630295]
[80]
Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 2014; 10(5): 261-75.
[http://dx.doi.org/10.1038/nrendo.2013.255] [PMID: 24366116]
[81]
Kuchiike D, Uto Y, Mukai H, et al. Degalactosylated/desialylated human serum containing GcMAF induces macrophage phagocytic activity and in vivo antitumor activity. Anticancer Res 2013; 33(7): 2881-5.
[PMID: 23780974]
[82]
Yamamoto N, Suyama H, Nakazato H, Yamamoto N, Koga Y. Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF. Cancer Immunol Immunother 2008; 57(7): 1007-16.
[http://dx.doi.org/10.1007/s00262-007-0431-z] [PMID: 18058096]
[83]
Yamamoto N, Suyama H, Yamamoto N, Ushijima N. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). Int J Cancer 2008; 122(2): 461-7.
[http://dx.doi.org/10.1002/ijc.23107] [PMID: 17935130]
[84]
Yamamoto N, Suyama H, Yamamoto N. Immunotherapy for prostate cancer with Gc protein-derived macrophage-activating factor, GcMAF. Transl Oncol 2008; 1(2): 65-72.
[http://dx.doi.org/10.1593/tlo.08106] [PMID: 18633461]
[85]
Yamamoto N, Ushijima N, Koga Y. Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF). J Med Virol 2009; 81(1): 16-26.
[http://dx.doi.org/10.1002/jmv.21376] [PMID: 19031451]
[86]
Koga Y, Naraparaju VR, Yamamoto N. Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice. Proc Soc Exp Biol Med 1999; 220(1): 20-6.
[http://dx.doi.org/10.1046/j.1525-1373.1999.d01-3.x] [PMID: 9893164]
[87]
Yamamoto N, Naraparaju VR. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor. Cancer Res 1997; 57(11): 2187-92.
[PMID: 9187119]
[88]
Korbelik M, Naraparaju VR, Yamamoto N. Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer. Br J Cancer 1997; 75(2): 202-7.
[http://dx.doi.org/10.1038/bjc.1997.34] [PMID: 9010027]

Rights & Permissions Print Cite
Article Metrics
54
8
1
1
© 2024 Bentham Science Publishers | Privacy Policy